Thirdeye Systems Ltd. Logo

Thirdeye Systems Ltd.

Develops AI object recognition algorithms and hardware for the thermal spectrum.

THES | TA

Overview

Corporate Details

ISIN(s):
IL0003970188
LEI:
Country:
Israel
Address:
8 Ha-Melakha St., 4250543 Netanya

Description

Thirdeye Systems Ltd. is a research and development company specializing in high-end, AI-powered object recognition algorithms, with a primary focus on the thermal spectrum. The company develops solutions that leverage deep neural networks and fuse thermal with visible light imaging to enable advanced perception. Its product portfolio includes both software analytics that can be integrated into third-party electro-optical/infrared (EO/IR) systems and complete hardware payloads. These systems are designed for applications such as counter-drone (C-UAV) security, perception for unmanned ground vehicles (UGV), and aerial surveillance. The technology provides real-time, automatic detection, classification, and tracking of objects like drones, vehicles, and humans in various operational conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-09-13 16:38
Opening of Trading On September 14 2022- THIRDEYE W2, THIRDEYE W3
Hebrew (modern) 176.1 KB
2022-09-12 16:03
Identifying Details of New Securities-THIRDEYE W2, THIRDEYE W3
Hebrew (modern) 89.2 KB
2022-05-01 11:29
Company's Presentation-May 2022
Hebrew (modern) 1.7 MB
2022-05-01 11:29
Company's Presentation-May 2022
Russian 42.6 KB
2021-06-03 14:17
Discontinuation of Market Making
Hebrew (modern) 186.2 KB
2021-05-20 20:31
On June 3th, 2021, following seasoned shares will be added to the respective in…
Hebrew (modern) 333.6 KB
2021-05-13 15:52
Changes in company's and securities names effective of May 18, 2021
Hebrew (modern) 149.3 KB
2021-04-12 10:25
change the sector classification of the company from - - REAL-ESTATE & CONSTRUC…
Hebrew (modern) 148.1 KB
2021-02-01 18:38
On February 2, 2021, the company's securities will be transferred from the main…
Hebrew (modern) 150.0 KB

Automate Your Workflow. Get a real-time feed of all Thirdeye Systems Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Thirdeye Systems Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Thirdeye Systems Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

KAZIA THERAPEUTICS LTD Logo
Oncology-focused biotech developing targeted therapies for cancers with high unmet needs.
United States of America
KZIA
Keros Therapeutics, Inc. Logo
Develops protein therapeutics for disorders linked to TGF-β signaling.
United States of America
KROS
Kura Oncology, Inc. Logo
Clinical-stage biopharma company developing precision medicines for cancer treatment.
United States of America
KURA
Larimar Therapeutics, Inc. Logo
A clinical-stage biotech developing treatments for complex rare diseases.
United States of America
LRMR
Lexaria Bioscience Corp. Logo
A biotech company with a patented platform to improve oral drug delivery and absorption.
United States of America
LEXX
LigaChem Biosciences Inc. Logo
Clinical-stage biopharma developing ADCs, immuno-oncology drugs, and small molecules.
South Korea
141080
Linical Co., Ltd. Logo
A global CRO providing a full spectrum of drug development services for biopharma.
Japan
2183
Lipigon Pharmaceuticals AB Logo
A clinical-stage company developing therapeutics for lipid-related disorders.
Sweden
LPGO
Lipum AB Logo
Clinical-stage biopharma developing novel treatments for chronic inflammatory diseases.
Sweden
LIPUM
LIXTE BIOTECHNOLOGY HOLDINGS, INC. Logo
Clinical-stage pharma company developing PP2A inhibitors to enhance cancer therapies.
United States of America
LIXT

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.